Near-Infrared Optical Imaging of Epidermal Growth Factor Receptor in Breast Cancer Xenografts

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7870-7875

  Ke, Shi ^a   Wen, Xiaoxia ^a   Gurfinkel, Michael ^b   Charnsangavej, Chusilp ^a   Wallace, Sidney ^a   Sevick Muraca, Eva M ^b   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; EPIDERMAL GROWTH FACTOR RECEPTOR; INDOCYANINE GREEN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOLOGICAL MONITORING; BREAST CARCINOMA; CAMERA; CANCER CELL; CANCER LOCALIZATION; CONTROLLED STUDY; DEVICE; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGE INTENSIFIER; IMAGING SYSTEM; IN VIVO STUDY; INFRARED RADIATION; INJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; WAVEFORM;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CARBOCYANINES; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; FEMALE; FLUORESCENT DYES; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPECTROSCOPY, NEAR-INFRARED; SUBSTRATE SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0344844469     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gurfinkel, M., Ke, S., Wen, X-X., Li, C., and Sevick-Muraca, E. M. Near-infrared fluorescence optical imaging and tomography. Dis. Mark., in press, 2003.
2. Hawrysz, D. J., and Sevick-Muraca, E. M. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia, 2: 388-417, 2000.
3. Folli, S., Westermann, P., Braichotte, D., Pelegrin, A., Wagnieres, G., van den Bergh, H., and Mach, J-P. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res., 54: 2643-2649, 1994.
4. Ballou, B., Fisher, G. W., Deng, J-S., Hakala, T. R., Srivastava, M., and Farkas, D. L. Cyanine fluorochrome-labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. Cancer Detect. Prev., 22: 251-257, 1998.
5. Bremer, C., Tung, C-H., and Weissleder, R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med., 6: 743-748, 2001.
6. Tung, C-H., Mahmood, U. Bredow, S., and Weissleder, R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res., 60: 4953-4958, 2000.
7. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am., 271: 58-65, 1994.
8. Achilefu, S., Dorshow, R. B., Bugaj, J. E., and Rajagopalan, R. Novel receptor-targeted fluorescent contrast agents for in vivo tumor targeting. Investig. Radiol., 35: 479-485, 2000.
9. Becker, A., Hessenius, C., Licha, K., Ebert, B., Sukowski, U., Semmler, W., Wiedenmann, B., and Grotzinger, C. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat. Biotechnol., 19: 327-331, 2001.
10. Bugaj, J. E., Achilefu, S., Dorshow, R. B., and Rajagopalan, R. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. J. Biomed. Opt., 6: 122-133, 2001.
11. Zaheer, A., Lenkinski, R. E., Mahmood, A., Jones, A. G., Cantley, L. C., and Frangioni, J. V. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat. Biotechnol., 19: 1148-1154, 2001.
12. Modjahedi, H., and Dean, C. The receptor for EGF and its ligands: expression, prognostic value and target for therapy in cancer. Int. J. Oncol., 4: 277-296, 1994.
13. Yasui, W., Sumiyoshi, H., Hata, J., Kameda, T., Ochiai, A., Ito, H., and Tahara, E. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res., 48: 137-141, 1988.
14. Costa, S., Stamm, H., Almendral, A., Ludwig, H., Wyss, R., Fabbro, D., Ernst, A., Takahashi, A., and Eppenberger, U. Predictive value of EGF receptor in breast cancer. Lancet, 2: 1258, 1988.
15. Ang, K. K., Berkey, B. A., Tu, X., Zhang, H-Z., Katz, R., Hammond, E. H., Fu, K. K., and Milas, L. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res., 62: 7350-7356, 2002.
16. Mendelsohn, J. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy. Clin. Cancer Res., 3: 2703-2707, 1997.
17. Schatten, C., Pateisky, N., Navra, N., Ehrenbock, P., Angelberger, P., Sivolapenko, G., and Epenetos, A. Lymphoscintigraphy with 123I-labeled epidermal growth factor. Lancet, 337: 395-396, 1991.
18. Goldenberg, A., Masui, H., Divgi, C., Kamrath, H., Pentlow, K., and Mendelsohn, J. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody. J. Natl. Cancer Inst. (Bethesda), 81: 1616-1625, 1989.
19. 111In-DTPA-poly(ethylene glycol) conjugated anti-EGF receptor antibody C225. J. Nucl. Med., 42: 1530-1537, 2001.
20. Divgi, C. R., Welt, S., Kris, M., Real, F. X., Yeh, S. D. J., Gralla, R., Merchant, B., Schweighart, S., Unger, M., Larson, S. M., and Mendelsohn, J. Phase 1 and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal anti-body 225 in patients with squamous cell lung carcinoma. J. Natl. Cancer Inst. (Bethesda), 83: 97-104, 1991.